## ED: Consolidated Edison, Inc. - XLU: Utilities

### Executive Summary

No thesis match: MRS_20 0.1% below STRENGTH zone (4.0-10.0%); PEG 3.31 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($96.23)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Argus Adjusts Price Target on Consolidated Edison to $108 From $112, Maintains Buy Rating**
- Source: marketscreener.com | 20260105T171003 | Somewhat-Bearish | Relevance: 100%
- Argus has adjusted its price target for Consolidated Edison (ED) to $108 from $112, while reaffirming a Buy rating on the stock. This update reflects a revised valuation for the utility company, maintaining a positive outlook despite the slight price target reduction. The article also lists recent analyst adjustments and company news for Consolidated Edison.

**2. ConEd’s Ex-Job Benefits Lawyer Nabs Limited Revival of Bias Suit**
- Source: Bloomberg Law News | 20260105T184120 | Somewhat-Bearish | Relevance: 100%
- A federal appeals court has granted a limited revival of a bias suit filed by Consolidated Edison Inc.'s former top job benefits lawyer. The ex-chief employee benefits counsel can now try to prove the company retaliated against her in violation of New York City law, although the appeals court affirmed her losses on other discrimination and retaliation claims. The district judge failed to properly analyze attorney Sharon Goldzweig’s New York City Human Rights Law retaliation allegations.

**3. ConEd’s Ex-Job Benefits Lawyer Nabs Limited Revival of Bias Suit**
- Source: Bloomberg Law News | 20260105T183900 | Somewhat-Bearish | Relevance: 100%
- A federal appeals court has allowed a former Consolidated Edison Co. of New York lawyer, Sharon Goldzweig, to proceed with a limited part of her bias lawsuit. While the court affirmed the dismissal of most of her discrimination and retaliation claims, it ruled that a district judge did not properly analyze her New York City Human Rights Law retaliation allegations. Goldzweig, who spent nearly two decades at ConEd, can now try again to prove the company retaliated against her.

**4. Goldman Sachs Warns US Grids Face Power Crunch by 2030**
- Source: Bloomberg.com | 20260106T164354 | Somewhat-Bearish | Relevance: 71%
- Goldman Sachs predicts that almost all US power grids will face a critical shortage of spare capacity by 2030 due to surging demand from data centers. This bottleneck in power supply could threaten the US's competitive edge in the artificial intelligence sector, potentially allowing China to gain an advantage, according to Samantha Dart, Goldman’s co-head of global commodities research.

**5. A Look At Sempra (SRE) Valuation As A Potential Regulatory Charge Weighs On Future Earnings**
- Source: Simply Wall Street | 20260105T232748 | Neutral | Relevance: 65%
- Sempra (SRE) faces a potential US$471 million after-tax charge to its Q4 2025 earnings due to a regulatory decision, impacting its valuation. While the company's LNG projects position it for future growth, the stock trades at a premium P/E ratio compared to its peers, raising questions about whether the market fully accounts for anticipated growth or if there's a valuation risk. Investors are prompted to consider the company's long-term potential against current market pricing and regulatory uncertainties.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | UBS | $104 | $112 | -7% |
| 2025-12-12 | JP Morgan | $97 | $101 | -4% |
| 2025-12-12 | Keybanc | $86 | $90 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | UBS | main | Neutral |
| 2025-12-12 | JP Morgan | main | Underweight |
| 2025-12-12 | Keybanc | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 1 ($0.22M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+0.3%)
- Blackrock Inc.: 11.4% (-0.1%)
- State Street Corpora: 6.7% (+0.3%)
- Geode Capital Manage: 2.8% (+1.8%)
- Lazard Asset Managem: 1.7% (+121543.9%)

### Key Risks

1. Valuation stretched: PEG 3.3x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.31 signals overvaluation risk, limited margin of safety. Forward P/E 16.5x stretched relative to 6% growth. Analyst sentiment negative (3 target cuts vs 0 raises). Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $35.8B |
| Beta | 0.38 |
| 52W Range | $87.28 - $114.87 |
| Short Interest | 3.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.31 |
| Forward P/E | 16.5 |
| Current P/E | 17.5 |
| YoY Growth | 6.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 1.9% to 0.1% (-1.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.0pp (needs >4.0% for momentum thesis). MRS_5 (-0.9%) diverging from MRS_20 - short-term weakness emerging. Below SMA200 (0.97x), long-term trend not supportive. RSI neutral at 52. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.05% (CS: 41) | Neutral |
| RSI_14 | 52.1 | Neutral |
| MACD Histogram | 0.10 | Bullish |
| vs SMA20 | 1.009x | Above |
| vs SMA50 | 1.006x | Above |
| vs SMA200 | 0.974x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $99.31
- **Stop Loss:** $96.23 (3.1% risk)
- **Target:** $102.39 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 357
- **Position Value:** $35,453.67
- **Portfolio %:** 35.45%
- **Risk Dollars:** $1,100.00
- **Risk Per Trade:** 1.10%
- **Modifiers:** L1 110% | L2 100% | Combined 1.10x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

**Next:** 2026-02-19 (Est: $0.86)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.75 | $1.90 | +8.3% |
| 2025Q2 | $0.66 | $0.67 | +1.8% |
| 2025Q1 | $2.21 | $2.26 | +2.4% |
| 2024Q4 | $0.96 | $0.98 | +2.1% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_20*